(Q39122722)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Clinical status and implications of antimalarial drug resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Steve Ward

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Peter A Winstanley

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

published in

Microbes and Infection

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

157-164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

Cost-effectiveness of malaria control in sub-Saharan Africa.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Access to hematin: the basis of chloroquine resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Preventing antimalarial drug resistance through combinations

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Using evidence to change antimalarial drug policy in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Malaria: living with drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901523-4

7 January 2021

10.1016/S1286-4579(01)01523-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880047%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference